Meloxicam 15 mg: Clinical Trials

6 trials of Meloxicam 15 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 unknown. 3 Phase 2, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 42Recruiting 2
Phase 31Unknown 1

Follow Meloxicam 15 mg: new trials by email Literature Review of Meloxicam 15 mg trials Research Report on Meloxicam 15 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Methylprednisolone for Pain Control After ACL Repair
Meloxicam 15 mg, Medrol 4 MG Oral Tablet Includes Medrol Dosepak, Gabapentin 300 mg - ACL Surgery, Pain Management
Phase 4RecruitingSt. Louis University902025-10-212026-11-19
Meloxicam in Mohs Micrographic Surgery
Meloxicam 7.5 mg, Meloxicam 15 mg, Acetaminophen 500mg - Postoperative Pain, Acute, Skin Cancer
Phase 4RecruitingUniversity of Oklahoma3002025-10-152025-12-15
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.192022-06-282026-09-09
Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?
Meloxicam 15 mg, Preoperative Interscalene Nerve Block, arthroscopic labral repair - Shoulder Pain
Phase 3UnknownRothman Institute Orthopaedics962021-01-252021-01-26
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar
Meloxicam 7.5 mg, Meloxicam 3.75 mg, Meloxicam 1.875 mg - Pain
Phase 2CompletedBoehringer Ingelheim3811998-04-012014-07-08
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
Meloxicam 7.5 mg, Meloxicam 15 mg, Mefenamic acid 500 mg - Dysmenorrhea
Phase 2CompletedBoehringer Ingelheim3371998-01-012018-08-31

Conditions studied

Pain (2)  ·  Agnosia (1)  ·  Dysmenorrhea (1)  ·  Pain, Postoperative (1)  ·  Shoulder Pain (1)  ·  Skin Neoplasms (1)

Sponsors

Boehringer Ingelheim (2)  ·  InnovaGyn, Inc. (1)  ·  Rothman Institute Orthopaedics (1)  ·  St. Louis University (1)  ·  University of Oklahoma (1)

Countries

United States (4)

Top investigators

David F. Archer, MD (1)  ·  Lindsey Collins, MD (1)  ·  Scott Kaar, MD (1)  ·  William L. McPheat, PhD (1)

Results publications

PMID 12441312, PMID 15541405, PMID 16009156, PMID 16798842, PMID 16855077, PMID 16980507, PMID 18929686, PMID 19933235, PMID 23040128, PMID 23114735, PMID 24835831, PMID 25259677, PMID 26025453, PMID 26830816

NIH funding

R43HD104508 (1)